Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm, Genomenon Partner to Develop Genomic Panel Design Services

NEW YORK (GenomeWeb) – Fluidigm has announced that it has entered a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease researchers.

According to the partners, researchers will be able to expedite the design of disease-specific next-generation sequencing, genotyping, and real-time PCR panels using Fluidigm's automated microfluidic systems.

Genomenon has designed its Mastermind Panel Design Service to identify disease-specific biomarkers for researchers using the firm's genomic search database and automated machine-learning algorithms. Genomenon then delivers a group of prioritized candidates to researchers to help in panel design. The Ann Arbor, Michigan-based firm claims its service can minimize target identification time from a year to a few weeks.

"This valuable addition to our custom genomic panel design offering represents an important building block in expanding the benefits of microfluidics technology to a wider range of disease reach areas," Fluidigm CEO and President Chris Linthwaite said in a statement.

Financial details of the collaboration were not disclosed.

Genomenon previously announced a co-marketing agreement with Swift Biosciences in May to design and create targeted gene sequencing panels.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.